Position in SCLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$39
-$34 QoQ
Shares Held
6
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Allworth Financial LP holds $325,693,383 across 18 Drug Manufacturers - General names. SCLX ranks #18 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
412,264 | $100,773,812 | |
| 2 | LLY |
ELI LILLY & Co
|
66,228 | $60,914,527 | |
| 3 | ABBV |
AbbVie Inc.
|
263,766 | $57,366,467 | |
| 4 | MRK |
Merck & Co., Inc.
|
262,901 | $31,624,361 | |
| 5 | AMGN |
Amgen Inc
|
54,554 | $19,194,824 | |
| 6 | NVS |
Novartis AG
|
96,473 | $14,736,250 | |
| 7 | PFE |
Pfizer Inc
|
484,920 | $13,616,553 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
220,900 | $13,397,585 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $39 | 6 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $73 | 6 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $118 | 6 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $76 | 13 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||